OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
688432 GRINM Semiconductor Materials
- 11.84
- -0.03-0.25%
Post Market Apr 1 15:00 CST
14.77BMarket Cap63.32P/E (TTM)
12.05High11.84Low43.62KlotVolume11.94Open11.87Pre Close52.08MTurnover0.86%Turnover Ratio63.32P/E (Static)1.25BShares14.5052wk High3.40P/B6.01BFloat Cap8.3052wk Low14.24Limit Up507.57MShs Float22.28Historical High9.50Limit Down1.77%Amplitude7.44Historical Low0.01Dividend TTM11.94Avg Price21.40KlotAsk0.08%Div YieldTTM100Lot Size20.87KlotBid
GRINM Semiconductor Materials Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 3.70%995.95M | -2.18%773.1M | -4.42%507.16M | -9.07%234.68M | -18.29%960.4M | -14.53%790.32M | -13.75%530.61M | -8.17%258.09M | 35.23%1.18B | 57.09%924.71M |
| Operating revenue | 3.70%995.95M | -2.18%773.1M | -4.42%507.16M | -9.07%234.68M | -18.29%960.4M | -14.53%790.32M | -13.75%530.61M | -8.17%258.09M | 35.23%1.18B | 57.09%924.71M |
| Total operating cost | 1.70%748.71M | -2.24%575.84M | 2.70%384.87M | -2.86%184.38M | -7.34%736.22M | -2.99%589.02M | -10.60%374.74M | -12.59%189.8M | -0.64%794.58M | 6.98%607.15M |
| Operating cost | 0.05%630.74M | -4.04%490.35M | 1.52%330.57M | -1.06%159.72M | -13.27%630.45M | -11.49%511M | -16.63%325.6M | -13.92%161.43M | 16.06%726.95M | 32.63%577.35M |
| Operating tax surcharges | -8.82%7.06M | -13.75%5.01M | -41.13%2.32M | -67.63%714.12K | -6.51%7.74M | -8.14%5.81M | -10.28%3.93M | 9.01%2.21M | -20.35%8.28M | -22.77%6.32M |
| Operating expense | -0.78%14.06M | -1.94%10.61M | -6.79%6.85M | -6.57%3.06M | 5.58%14.17M | 7.75%10.82M | 17.26%7.35M | 11.12%3.28M | -24.56%13.42M | -30.80%10.05M |
| Administration expense | 17.15%39.08M | 11.76%24.82M | 3.97%15.3M | 1.58%7.34M | -11.64%33.36M | -7.40%22.2M | -1.11%14.71M | 0.74%7.22M | -46.47%37.75M | -57.13%23.98M |
| Financial expense | 35.32%-20.52M | 47.70%-13.76M | 34.90%-13.24M | -9.50%-8.01M | 58.55%-31.72M | 62.87%-26.3M | 40.08%-20.34M | -1,244.94%-7.31M | -4,148.62%-76.52M | -1,273.85%-70.84M |
| -Interest expense (Financial expense) | 56.86%338.85K | 682.36%273.54K | 1,852.91%198.48K | 205.43%109.44K | 71.60%216.02K | -64.48%34.96K | -85.74%10.16K | -6.75%35.83K | -38.02%125.88K | -42.45%98.42K |
| -Interest Income (Financial expense) | 21.87%-20.45M | 15.27%-16.99M | 14.65%-12.65M | 4.77%-8.08M | -36.76%-26.17M | -81.44%-20.05M | -230.86%-14.81M | -277.96%-8.48M | -104.71%-19.13M | -67.86%-11.05M |
| Research and development | -4.79%78.28M | -10.20%58.8M | -0.92%43.08M | -6.19%21.55M | -2.93%82.22M | 8.60%65.48M | 17.39%43.48M | 27.65%22.98M | 10.85%84.7M | 2.65%60.29M |
| Credit Impairment Loss | -275.60%-939.42K | -191.04%-1.16M | -250.65%-1.29M | 9.57%-718.88K | -203.62%-250.11K | 39.67%-400.17K | 40.12%-367.05K | -353.41%-794.92K | 170.98%241.39K | 39.41%-663.27K |
| Asset Impairment Loss | 131.08%2.64M | 153.18%1.55M | 155.27%1.64M | 134.98%1.04M | -31,843.85%-8.48M | -886.19%-2.92M | -405.76%-2.97M | -468.39%-2.98M | 102.14%26.73K | 116.31%371.79K |
| Other net revenue | ||||||||||
| Fair value change income | 5.62%13.3M | 24.35%13.23M | 11.54%7.53M | -2.69%3.13M | 3,453.40%12.59M | --10.64M | --6.75M | --3.21M | --354.3K | ---- |
| Invest income | -124.08%-4.94M | -129.23%-4.16M | -31.23%5.61M | 99.24%2.78M | 529.09%20.53M | 382.02%14.22M | 368.10%8.15M | 153.50%1.4M | -660.47%-4.78M | -581.37%-5.04M |
| -Including: Investment income associates | -186.41%-35.18M | -149.51%-21.02M | -112.24%-9.56M | -76.39%-4.13M | -20.23%-12.28M | -12.98%-8.42M | -1.25%-4.5M | 25.34%-2.34M | -346.02%-10.22M | -544.62%-7.46M |
| Asset deal income | 7,784.53%84.5K | 5,116.82%55.17K | 5,116.82%55.17K | ---- | ---1.1K | ---1.1K | ---1.1K | --18.65K | ---- | ---- |
| Other revenue | -19.53%60.79M | -25.46%46.45M | -19.07%32.44M | -34.39%16.71M | 42.81%75.54M | 42.91%62.31M | 23.73%40.09M | 102.76%25.47M | -46.44%52.9M | -38.37%43.6M |
| Operating profit | -1.83%318.16M | -11.20%253.22M | -18.91%168.29M | -22.58%73.25M | -24.53%324.11M | -19.86%285.15M | -8.07%207.53M | 27.02%94.61M | 156.65%429.47M | 297.36%355.82M |
| Add:Non operating Income | 158.89%1.48M | -14.48%79.84K | -68.65%25.98K | -100.00%1.09 | 5.13%572.51K | -81.38%93.36K | -83.40%82.86K | -92.85%31.77K | -97.20%544.59K | -97.40%501.29K |
| Less:Non operating expense | 403.66%1.35M | -39.21%41.06K | 613.48%33.39K | 18,799.24%25.89K | -63.29%268.31K | 6,228.31%67.54K | --4.68K | --137 | 760.55%730.95K | -98.71%1.07K |
| Total profit | -1.89%318.29M | -11.19%253.26M | -18.95%168.28M | -22.63%73.22M | -24.43%324.41M | -19.97%285.18M | -8.24%207.61M | 26.31%94.64M | 129.94%429.28M | 227.75%356.32M |
| Less:Income tax cost | 35.72%49.07M | -7.28%30.78M | -17.44%19.98M | 12.64%9.51M | --36.15M | 738.97%33.2M | 651.99%24.2M | 627.83%8.44M | ---- | 5,731.25%3.96M |
| Net profit | -6.60%269.23M | -11.71%222.48M | -19.14%148.3M | -26.08%63.72M | -32.85%288.26M | -28.49%251.97M | -17.77%183.41M | 16.85%86.2M | 129.94%429.28M | 224.31%352.36M |
| Net profit from continuing operation | -6.60%269.23M | -11.71%222.48M | -19.14%148.3M | -26.08%63.72M | -32.85%288.26M | -28.49%251.97M | -17.77%183.41M | 16.85%86.2M | 129.94%429.28M | --352.36M |
| Less:Minority Profit | 6.59%36.32M | -6.71%27.8M | -18.92%17.82M | -18.25%7.33M | -56.29%34.08M | -53.73%29.79M | -45.40%21.97M | -33.30%8.97M | 103.37%77.96M | 155.07%64.39M |
| Net profit of parent company owners | -8.37%232.9M | -12.38%194.68M | -19.17%130.48M | -26.99%56.38M | -27.65%254.18M | -22.85%222.18M | -11.68%161.44M | 28.03%77.23M | 136.80%351.33M | 245.27%287.98M |
| Earning per share | ||||||||||
| Basic earning per share | -8.15%0.1871 | -11.11%0.16 | -23.08%0.1 | -16.67%0.05 | -36.34%0.2037 | -33.33%0.18 | -23.53%0.13 | 0.00%0.06 | 113.33%0.32 | 200.00%0.27 |
| Diluted earning per share | -8.15%0.1871 | -11.11%0.16 | -23.08%0.1 | -16.67%0.05 | -36.34%0.2037 | -33.33%0.18 | -23.53%0.13 | 0.00%0.06 | 113.33%0.32 | 200.00%0.27 |
| Other composite income | ||||||||||
| Total composite income | -6.60%269.23M | -11.71%222.48M | -19.14%148.3M | -26.08%63.72M | -32.85%288.26M | -28.49%251.97M | -17.77%183.41M | 16.85%86.2M | 129.94%429.28M | 224.31%352.36M |
| Total composite income of parent company owners | -8.37%232.9M | -12.38%194.68M | -19.17%130.48M | -26.99%56.38M | -27.65%254.18M | -22.85%222.18M | -11.68%161.44M | 28.03%77.23M | 136.80%351.33M | 245.27%287.98M |
| Total composite income of minority owners | 6.59%36.32M | -6.71%27.8M | -18.92%17.82M | -18.25%7.33M | -56.29%34.08M | -53.73%29.79M | -45.40%21.97M | -33.30%8.97M | 103.37%77.96M | 155.07%64.39M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | -- | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.